Looking to Navigate Compliance, Generate Sales, and Build your Unlicensed Medicine Portfolio?
Empowering you to focus on your strengths while we expertly manage your Medicinal Cannabis business. Leave the heavy lifting to us – we’ve got your back!
UK Prescriptions
In 2024, private medicinal cannabis prescriptions doubled according the Care Quality Commission (CQC)
Rapid Expansion
The UK medicinal cannabis market is projected to grow from its current value (approximately £700 million in 2025) to potentially over £1 billion by 2028
Our Mission
At Medicexum, we empower businesses and healthcare professionals in the medicinal cannabis sector with expert guidance, innovative strategies, and compliance-driven solutions to advance safe access and industry growth
Market Growth
- Patient Access: More patients are likely to be prescribed medical cannabis as awareness among healthcare professionals and the general public grows.
- Insurance Coverage: There could be advancements in making cannabis-based medicines eligible for broader insurance or NHS support.
Opportunity
Cannabis Based-Medicinal Products (CBMPs)
Import/Export Support
At Medicexum, we offer solutions for importation of medical cannabis into the UK through fully licensed, EU GMP-compliant producers, ensuring regulatory approvals, seamless compliance, and safe delivery for patients and healthcare providers.
Product Selection
We can support identfying various medical cannabis product forms, including vapes for fast relief, gummies for discretion, flower for inhalation, oils for precise dosing, and capsules for consistent effects, catering to diverse patient needs.
B2B Access
Medicexum supports B2B clients with expert guidance on licensing, compliance, sourcing EU GMP-certified products, and market strategies to drive success in the medical cannabis industry.
Research & development
Study of clinical outcomes of medicinal cannabis therapy for ADHD
The UK Medical Cannabis Registry has published several observational studies indicating that patients prescribed cannabis-based medicinal products reported improvements in conditions such as anxiety, sleep disorders, and general health-related quality of life. For instance, a study focusing on patients with Attention Deficit Hyperactivity Disorder (ADHD) found significant enhancements in anxiety levels, sleep quality, and overall health-related quality of life over a 12-month period. The treatment was well tolerated, with fewer than one in five individuals reporting adverse events during the therapy.
As of 2024, the number of medical cannabis patients in the UK is estimated to be approximately only 0.09% of the UK’s population of around 67 million.
%
Approximately 28 million of the population in the UK live with chronic pain. With a significant proportion might explore medical cannabis as an alternative or supplement to traditional pain management.
Surveys suggest that upto 6% of the UK adult population have expressed an interest in using medical cannabis if it were more accessible. Among patients managing chronic conditions, this number could be much higher, particularly as awareness and availability increase.
Ready to break into the UK medicinal cannabis market while staying fully compliant? Partner with Medicexum today! Our expert team delivers tailored strategies and solutions to drive your success. Let’s turn your vision into reality - get in touch now!
How We Can Help
Identify Suppliers
We operate within a fully compliant supply chain, adhering to all regulatory standards to ensure the safe and legal production, distribution, and supply of medical cannabis products.
Setup Compliant Supply Chain
We specialise in setting up fully compliant medical cannabis supply chains, ensuring regulatory adherence, seamless operations, and access to high-quality products.
Calling All Suppliers, Producers & B2B Partners! Collaborate with Medicexum to Bring Compliant Medicinal Cannabis to UK Patients
Medicexum Blog | UK Medical Cannabis News & Insights
How to Become a Responsible Person (RP) in the UK Medical Cannabis Industry – A Step-by-Step Guide
The Responsible Person (RP) plays a critical role in the UK medical cannabis industry, ensuring compliance with Good Distribution Practice (GDP) and Medicines and Healthcare products Regulatory Agency (MHRA) regulations. If you are looking to become an RP in this...
How Media Bias is Holding Back the Cannabis Industry
The medicinal cannabis industry has made significant strides in recent years, with growing acceptance from medical professionals, regulators, and consumers. However, despite scientific advancements and evolving legislation, public perception remains a major hurdle....
The Importance of MHRA Compliance for UK Medical Cannabis Brands
In recent years, the UK’s medical cannabis industry has seen rapid growth, with increasing numbers of patients seeking prescriptions for a variety of health conditions. However, with this expansion comes increased scrutiny from regulators, the media, and the general...
UK Medical Cannabis Stability Testing: ICH Guidelines & Compliance
Medical cannabis stability studies are a crucial aspect of ensuring product safety, efficacy, and compliance with UK, European, and international regulatory frameworks. In the UK, stability testing must adhere to ICH guidelines, as well as the British Pharmacopoeia...
Why Now is the Best Time to Invest in the UK Medical Cannabis Market
The UK medical cannabis industry is experiencing rapid growth, driven by regulatory advancements, increasing patient demand, and expanding investment opportunities. With the UK government taking steps to create a structured framework for medical cannabis, now is the...
The Global Cannabis Market 2024: Key Insights & Trends
The global cannabis industry is experiencing dynamic changes in legalisation, market expansion, and medical cannabis accessibility. Businesses and investors must stay informed about policy shifts, emerging markets, and growth opportunities. At Medicexum, we provide...